Viewing StudyNCT04456049



Ignite Creation Date: 2024-05-06 @ 2:54 PM
Last Modification Date: 2024-10-26 @ 1:39 PM
Study NCT ID: NCT04456049
Status: TERMINATED
Last Update Posted: 2022-08-10
First Post: 2020-07-01

Brief Title: Randomized Open Label Phase II Study to Evaluate the Efficacy of Enzalutamide in High Risk Male Outpatients With COVID-1
Sponsor: Ricardo Pereira Mestre
Organization: Ente Ospedaliero Cantonale Bellinzona

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-08-24
Start Date Type: ACTUAL
Primary Completion Date: 2021-06-09
Primary Completion Date Type: ACTUAL
Completion Date: 2021-06-09
Completion Date Type: ACTUAL
First Submit Date: 2020-07-01
First Submit QC Date: July 1 2020
Study First Post Date: 2020-07-02
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2022-08-07
Last Update Post Date: 2022-08-10
Last Update Post Date Type: ACTUAL